News

Olmesartan Delays Microalbuminuria in Type 2


 

From the New England Journal of Medicine

JULIE INGELFINGER, M.D., is deputy editor of the New England Journal of Medicine. She disclosed having received travel/accommodations/meeting expenses from the National Institutes of Health and the Cystinosis Research Foundation. These comments were excerpted from an editorial that accompanied the study (N. Engl. J. Med.2011;384:970-1).

Pages

Recommended Reading

Psoriasis Doubles Risk of Metabolic Syndrome
MDedge Endocrinology
Stable Angina Twice as Deadly in Diabetes
MDedge Endocrinology
Venular Size May Predict Retinopathy Course
MDedge Endocrinology
Pharmacist in Practice Improved Glucose Control
MDedge Endocrinology
Patient Mentoring Improves Diabetes Control : Improvements in HbA1c, diet, and exercise were seen in the mentors as well as their mentees.
MDedge Endocrinology
Diabetes, Depression Raise Mortality in Women
MDedge Endocrinology
Bypassing Duodenum Seen to Resolve Diabetes : Improvements in HbA1c, lipids, and insulin were greater with gastric bypass than with restriction.
MDedge Endocrinology
Bariatric Surgery Effective in Minorities at 3-Year Follow-Up
MDedge Endocrinology
Enterovirus Risk Is 10-Fold Greater in Type 1
MDedge Endocrinology
Insulin Regulator Gene Tied to Type 2 Diabetes
MDedge Endocrinology